Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Soheila Korourian

Concepts (300)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
30
2018
1179
2.320
 Why?
Carcinoma, Ductal, Breast
9
2015
90
1.540
 Why?
Mastectomy, Segmental
8
2015
91
1.270
 Why?
Catheter Ablation
4
2014
123
1.090
 Why?
Neoplasm Recurrence, Local
7
2014
613
1.020
 Why?
Sentinel Lymph Node Biopsy
15
2017
117
1.000
 Why?
Mastectomy
10
2018
141
0.960
 Why?
Mammary Neoplasms, Experimental
7
2010
121
0.860
 Why?
Soybean Proteins
4
2023
161
0.830
 Why?
Biopsy, Needle
11
2017
181
0.820
 Why?
Obesity
8
2023
1108
0.810
 Why?
Carcinoma in Situ
3
2008
72
0.790
 Why?
Lymph Nodes
12
2017
263
0.760
 Why?
Caseins
4
2023
78
0.750
 Why?
9,10-Dimethyl-1,2-benzanthracene
4
2015
50
0.730
 Why?
Liver
9
2023
1116
0.690
 Why?
DNA, Neoplasm
1
2018
147
0.600
 Why?
Isoflavones
5
2023
89
0.600
 Why?
Rats, Zucker
9
2023
68
0.540
 Why?
Uterine Cervical Neoplasms
3
2007
276
0.490
 Why?
Receptor, erbB-2
3
2018
74
0.480
 Why?
Aged
32
2018
9405
0.470
 Why?
Receptors, Estrogen
4
2018
131
0.460
 Why?
Dietary Supplements
2
2015
434
0.460
 Why?
Arginine
1
2015
179
0.460
 Why?
Middle Aged
34
2018
12206
0.440
 Why?
Female
51
2018
26635
0.440
 Why?
Neoplasm Staging
15
2015
738
0.440
 Why?
Mammary Neoplasms, Animal
2
2015
35
0.410
 Why?
Diet
2
2015
557
0.410
 Why?
Ultrasonography, Mammary
4
2015
60
0.390
 Why?
Fatty Liver
3
2023
127
0.380
 Why?
Carcinogens
3
2015
198
0.370
 Why?
Antigens, Tumor-Associated, Carbohydrate
2
2008
24
0.370
 Why?
Benz(a)Anthracenes
1
2010
3
0.370
 Why?
Dehydroepiandrosterone
1
2010
15
0.360
 Why?
Rats
15
2023
3299
0.350
 Why?
Axilla
9
2017
90
0.350
 Why?
Aged, 80 and over
15
2018
3154
0.340
 Why?
Lymphatic Vessels
4
2014
48
0.340
 Why?
Adult
25
2018
13325
0.320
 Why?
Plant Lectins
1
2008
8
0.310
 Why?
Prognosis
11
2017
1954
0.310
 Why?
Carcinoma, Ductal
1
2008
9
0.310
 Why?
Magnetic Resonance Imaging
4
2014
1541
0.300
 Why?
Technetium Tc 99m Sulfur Colloid
6
2014
31
0.300
 Why?
Receptors, Progesterone
4
2018
64
0.290
 Why?
Electrosurgery
1
2007
7
0.290
 Why?
Humans
47
2019
50209
0.280
 Why?
Lymphedema
5
2017
43
0.280
 Why?
Thinness
3
2017
45
0.280
 Why?
Lymphatic Metastasis
12
2015
227
0.270
 Why?
Cytodiagnosis
4
2015
42
0.270
 Why?
Prospective Studies
12
2017
2379
0.260
 Why?
Animals
19
2023
13246
0.260
 Why?
Follow-Up Studies
10
2015
2190
0.260
 Why?
Nipples
5
2013
33
0.260
 Why?
Combined Modality Therapy
5
2014
636
0.260
 Why?
Adenocarcinoma, Mucinous
1
2005
18
0.250
 Why?
Endometritis
1
2004
9
0.240
 Why?
Ethanol
5
2010
341
0.240
 Why?
Proteoglycans
1
2004
80
0.230
 Why?
Radiopharmaceuticals
6
2014
208
0.230
 Why?
Carcinoma, Intraductal, Noninfiltrating
3
2013
40
0.230
 Why?
Proliferating Cell Nuclear Antigen
1
2003
75
0.220
 Why?
Laser Coagulation
1
2003
26
0.220
 Why?
Membrane Glycoproteins
1
2004
246
0.220
 Why?
Plasma Cells
1
2004
223
0.210
 Why?
Lymph Node Excision
6
2017
137
0.210
 Why?
Neoplasm Invasiveness
5
2015
266
0.210
 Why?
Carcinoma, Lobular
3
2015
33
0.210
 Why?
Coloring Agents
4
2014
70
0.210
 Why?
Mammaplasty
2
2013
43
0.200
 Why?
Infant Food
1
2002
28
0.200
 Why?
Uterine Cervical Dysplasia
3
2007
49
0.200
 Why?
Biopsy, Fine-Needle
3
2015
103
0.200
 Why?
Monitoring, Intraoperative
3
2014
54
0.190
 Why?
Ovarian Neoplasms
1
2005
447
0.180
 Why?
Immunohistochemistry
9
2017
978
0.180
 Why?
Biopsy
4
2007
590
0.180
 Why?
Ultrasonography, Interventional
3
2011
136
0.180
 Why?
Paraffin Embedding
2
2018
53
0.170
 Why?
Retrospective Studies
13
2015
6134
0.170
 Why?
Body Weight
3
2017
512
0.170
 Why?
Lung Neoplasms
3
2015
605
0.170
 Why?
Sensitivity and Specificity
8
2015
863
0.170
 Why?
Adolescent
8
2015
6390
0.170
 Why?
Neoplasm Grading
3
2014
123
0.160
 Why?
Tissue Fixation
1
2018
37
0.160
 Why?
Specimen Handling
1
2018
55
0.150
 Why?
Alanine Transaminase
3
2015
124
0.150
 Why?
Rats, Sprague-Dawley
7
2015
1586
0.130
 Why?
Treatment Outcome
5
2017
5155
0.130
 Why?
Pulmonary Medicine
1
2015
15
0.130
 Why?
Protein Hydrolysates
1
2015
6
0.130
 Why?
Aspartate Aminotransferases
1
2015
45
0.130
 Why?
Kaplan-Meier Estimate
2
2014
465
0.130
 Why?
Plant Extracts
1
2017
171
0.120
 Why?
Rosaniline Dyes
1
2014
8
0.120
 Why?
Image-Guided Biopsy
1
2015
33
0.120
 Why?
Sulfotransferases
1
2015
40
0.120
 Why?
Dermatologic Surgical Procedures
2
2013
34
0.120
 Why?
Young Adult
6
2015
3981
0.120
 Why?
Vacuum
2
2011
13
0.120
 Why?
Melanoma
2
2011
290
0.120
 Why?
Ultrasonography, Doppler
1
2014
42
0.110
 Why?
Interleukin-6
1
2015
265
0.110
 Why?
Tumor Necrosis Factor-alpha
1
2015
388
0.110
 Why?
Patient Care Planning
1
2013
67
0.110
 Why?
Carcinoma, Adenoid Cystic
1
2013
5
0.110
 Why?
Intraoperative Care
2
2011
54
0.110
 Why?
Disease-Free Survival
1
2014
454
0.110
 Why?
Preoperative Care
1
2014
166
0.100
 Why?
Skin Neoplasms
2
2011
492
0.100
 Why?
Lymphography
1
2011
9
0.100
 Why?
Image Processing, Computer-Assisted
2
2003
246
0.100
 Why?
Frozen Sections
1
2011
13
0.090
 Why?
Liver Neoplasms
2
2005
328
0.090
 Why?
Male
10
2023
25399
0.090
 Why?
Clinical Competence
1
2013
392
0.090
 Why?
Cytoprotection
1
2010
35
0.090
 Why?
DNA Methylation
1
2015
550
0.090
 Why?
Fatty Liver, Alcoholic
1
2010
7
0.090
 Why?
Drug Evaluation, Preclinical
1
2010
143
0.090
 Why?
Genistein
1
2010
46
0.090
 Why?
Feasibility Studies
1
2011
380
0.090
 Why?
Cell Line, Tumor
3
2010
1416
0.080
 Why?
Hepatocytes
2
2008
182
0.080
 Why?
Pilot Projects
1
2011
697
0.080
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
990
0.080
 Why?
Radionuclide Imaging
4
2011
118
0.080
 Why?
Hepatitis
1
2008
21
0.080
 Why?
Nuclear Magnetic Resonance, Biomolecular
1
2007
30
0.070
 Why?
Cytokines
2
2008
613
0.070
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2007
55
0.070
 Why?
Protons
1
2007
69
0.070
 Why?
Ovariectomy
1
2007
117
0.070
 Why?
Organ Size
1
2007
225
0.070
 Why?
Oligosaccharides
1
2005
34
0.060
 Why?
Cystadenocarcinoma, Papillary
1
2005
14
0.060
 Why?
Antibodies, Neoplasm
1
2005
28
0.060
 Why?
Omentum
1
2005
14
0.060
 Why?
Aging
1
2010
688
0.060
 Why?
Uterine Neoplasms
1
2005
60
0.060
 Why?
Monosaccharide Transport Proteins
1
2004
14
0.060
 Why?
Eosine Yellowish-(YS)
1
2004
5
0.060
 Why?
Carcinoma, Small Cell
1
2004
25
0.060
 Why?
Syndecans
1
2004
34
0.060
 Why?
Hematoxylin
1
2004
7
0.060
 Why?
Syndecan-1
1
2004
72
0.060
 Why?
Endometrium
1
2004
41
0.060
 Why?
Endotoxins
1
2004
34
0.060
 Why?
Immunoenzyme Techniques
1
2004
145
0.060
 Why?
Carbohydrates
1
2004
40
0.060
 Why?
Lymphoma, Non-Hodgkin
1
2004
59
0.060
 Why?
Liver Diseases, Alcoholic
1
2004
35
0.060
 Why?
Cytological Techniques
1
2003
14
0.060
 Why?
Apoproteins
1
2003
14
0.060
 Why?
Neoplasms, Multiple Primary
1
2003
44
0.060
 Why?
Fatty Acids
1
2004
145
0.060
 Why?
Dietary Fats
1
2004
124
0.060
 Why?
Malondialdehyde
1
2003
51
0.050
 Why?
Neoplasms
2
2004
1249
0.050
 Why?
Gene Expression
2
2019
609
0.050
 Why?
Gene Expression Regulation
1
2008
979
0.050
 Why?
Risk Factors
1
2011
3629
0.050
 Why?
Cell Membrane
1
2004
251
0.050
 Why?
Aldehydes
1
2003
83
0.050
 Why?
Overweight
1
2005
217
0.050
 Why?
Cytochrome P-450 CYP2E1
3
2010
113
0.050
 Why?
Surgical Instruments
1
2002
28
0.050
 Why?
Breast Diseases
1
2002
26
0.050
 Why?
Foreign-Body Migration
1
2002
32
0.050
 Why?
Hematoma
3
2010
66
0.050
 Why?
Asia
1
2002
18
0.050
 Why?
Chronic Disease
1
2004
571
0.050
 Why?
Carcinoma, Squamous Cell
1
2004
318
0.050
 Why?
Head and Neck Neoplasms
1
2004
273
0.050
 Why?
Cost-Benefit Analysis
2
2015
273
0.050
 Why?
Time Factors
1
2007
2922
0.050
 Why?
Neoplasm Metastasis
2
2015
236
0.040
 Why?
Cytokine Receptor Common beta Subunit
1
2019
2
0.040
 Why?
Health Status
1
2002
296
0.040
 Why?
Methyltransferases
1
2019
29
0.040
 Why?
Disease Progression
2
2015
831
0.040
 Why?
Apoptosis
1
2005
1112
0.040
 Why?
Child, Preschool
1
2008
3883
0.040
 Why?
Cohort Studies
2
2015
1422
0.040
 Why?
Alcohol Dehydrogenase
2
2010
38
0.040
 Why?
Arm
2
2009
47
0.040
 Why?
Oxidative Stress
3
2010
771
0.040
 Why?
Stereotaxic Techniques
2
2010
37
0.040
 Why?
Anti-Bacterial Agents
1
2004
747
0.040
 Why?
Polymerase Chain Reaction
1
2019
454
0.040
 Why?
Risk Assessment
2
2017
1262
0.040
 Why?
Disease Models, Animal
2
2015
1458
0.030
 Why?
Feces
1
2017
131
0.030
 Why?
Injections, Intralesional
2
2008
31
0.030
 Why?
Reproducibility of Results
2
2015
1185
0.030
 Why?
Adiponectin
1
2017
64
0.030
 Why?
Phylogeny
1
2017
234
0.030
 Why?
Lipid Metabolism
1
2017
175
0.030
 Why?
Leptin
1
2017
140
0.030
 Why?
Child
1
2008
6852
0.030
 Why?
Cost Savings
1
2015
60
0.030
 Why?
Protective Agents
1
2015
14
0.030
 Why?
Taxoids
1
2015
37
0.030
 Why?
MCF-7 Cells
1
2015
69
0.030
 Why?
Mice, Inbred BALB C
2
2005
305
0.030
 Why?
Insulin
1
2017
456
0.030
 Why?
CpG Islands
1
2015
107
0.030
 Why?
Infant, Newborn
1
2002
2766
0.030
 Why?
Cyclophosphamide
1
2015
166
0.030
 Why?
Touch
1
2013
25
0.030
 Why?
Tumor Cells, Cultured
1
2015
468
0.030
 Why?
Neoadjuvant Therapy
1
2015
117
0.030
 Why?
Biopsy, Large-Core Needle
1
2013
31
0.030
 Why?
Carcinoma
1
2015
139
0.030
 Why?
Infant
1
2002
3563
0.030
 Why?
Angiogenesis Inhibitors
1
2015
188
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2015
225
0.030
 Why?
Radiotherapy, Adjuvant
1
2013
61
0.030
 Why?
Hormones
1
2013
57
0.030
 Why?
Chemotherapy, Adjuvant
1
2013
120
0.030
 Why?
Injections, Intradermal
1
2011
14
0.020
 Why?
X-Rays
1
2011
55
0.020
 Why?
United States
1
2002
4874
0.020
 Why?
Antineoplastic Agents
2
2013
1186
0.020
 Why?
Cicatrix
1
2011
40
0.020
 Why?
Intraoperative Period
1
2011
45
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2015
828
0.020
 Why?
Diagnosis, Differential
2
2004
1043
0.020
 Why?
Predictive Value of Tests
2
2004
905
0.020
 Why?
Allyl Compounds
1
2010
11
0.020
 Why?
Sulfides
1
2010
28
0.020
 Why?
Survival Rate
1
2012
901
0.020
 Why?
Chemokines
1
2010
78
0.020
 Why?
Double-Blind Method
1
2011
688
0.020
 Why?
Transforming Growth Factor beta1
1
2010
60
0.020
 Why?
Mammary Glands, Animal
1
2010
69
0.020
 Why?
Cell Division
1
2010
295
0.020
 Why?
Endoplasmic Reticulum
1
2010
118
0.020
 Why?
Pyrazoles
1
2010
114
0.020
 Why?
Tissue Extracts
1
2007
13
0.020
 Why?
Pregnancy
1
2015
2604
0.020
 Why?
Least-Squares Analysis
1
2007
43
0.020
 Why?
Biotransformation
1
2007
85
0.020
 Why?
Electrocoagulation
1
2007
12
0.020
 Why?
Enzyme Inhibitors
1
2010
386
0.020
 Why?
Survival Analysis
1
2009
666
0.020
 Why?
Solubility
1
2007
71
0.020
 Why?
Observer Variation
1
2007
129
0.020
 Why?
Enteral Nutrition
1
2008
147
0.020
 Why?
Staining and Labeling
1
2007
97
0.020
 Why?
Positron-Emission Tomography
1
2008
294
0.020
 Why?
E-Selectin
1
2005
14
0.020
 Why?
Body Weights and Measures
1
2005
17
0.020
 Why?
Wheat Germ Agglutinins
1
2005
3
0.020
 Why?
Vaccines, Subunit
1
2005
15
0.020
 Why?
Vaccines, DNA
1
2005
11
0.020
 Why?
Gadolinium
1
2005
43
0.020
 Why?
Cross Reactions
1
2005
42
0.020
 Why?
Cytotoxicity, Immunologic
1
2005
55
0.020
 Why?
Growth Inhibitors
1
2005
27
0.020
 Why?
Gene Amplification
1
2005
57
0.020
 Why?
Ligands
1
2005
205
0.020
 Why?
Mice
2
2005
5759
0.020
 Why?
Glucose Transporter Type 1
1
2004
17
0.020
 Why?
Imaging, Three-Dimensional
1
2005
153
0.010
 Why?
Free Radicals
1
2004
28
0.010
 Why?
Sampling Studies
1
2004
37
0.010
 Why?
In Situ Hybridization, Fluorescence
1
2005
259
0.010
 Why?
Enzyme Induction
1
2004
79
0.010
 Why?
Corn Oil
1
2004
12
0.010
 Why?
Hyperplasia
1
2004
96
0.010
 Why?
Eye Neoplasms
1
2004
10
0.010
 Why?
Contrast Media
1
2005
185
0.010
 Why?
MART-1 Antigen
1
2004
12
0.010
 Why?
Species Specificity
1
2004
192
0.010
 Why?
Amino Acid Sequence
1
2005
586
0.010
 Why?
Injections
1
2003
56
0.010
 Why?
Dietary Carbohydrates
1
2004
86
0.010
 Why?
Necrosis
1
2004
178
0.010
 Why?
Rats, Wistar
1
2004
222
0.010
 Why?
Cell Proliferation
1
2008
1013
0.010
 Why?
Molecular Sequence Data
1
2005
793
0.010
 Why?
Regression Analysis
1
2004
395
0.010
 Why?
Cytoplasm
1
2004
91
0.010
 Why?
Energy Intake
1
2004
165
0.010
 Why?
Cytochrome P-450 Enzyme System
1
2004
195
0.010
 Why?
Cell Nucleus
1
2004
187
0.010
 Why?
Multivariate Analysis
1
2004
581
0.010
 Why?
Antigens, Neoplasm
1
2004
152
0.010
 Why?
Glutathione
1
2004
296
0.010
 Why?
Sex Characteristics
1
2004
191
0.010
 Why?
Antioxidants
1
2004
241
0.010
 Why?
Confidence Intervals
1
2002
156
0.010
 Why?
Models, Theoretical
1
2002
174
0.010
 Why?
Neoplasm Proteins
1
2004
324
0.010
 Why?
Reoperation
1
2002
454
0.010
 Why?
Korourian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (300) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department